A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab

Clinical trial NCT01502423 · COMPLETED

Trial details

NCT number: NCT01502423
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2012-01-01
Primary completion: 2012-11-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.